Blood Glucose and Renal Function Evaluation in Patients with Viral Hepatitis

References

• Jefferies M , Rauff B , Rashid H , Lam T , Rafiq S . Update on global epidemiology of viral hepatitis and preventive strategies. World J Clin Cases . 2018;6(13):589–599. doi:10.12998/wjcc.v6.i13.589 30430114
   PubMed Web of Science ®Google Scholar
• World Health Organization.. Global hepatitis report 2017; 2017. https://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/. Accessed 5 13, 2021.
   Google Scholar
• Iovanescu VF , Streba CT , Ionescu M , et al. Diabetes mellitus and renal involvement in chronic viral liver disease. J Med Life . 2015;8(4):483–487.26664475
   PubMedGoogle Scholar
• Younossi ZM , Birerdinc A , Henry L . Hepatitis C infection: a multi-faceted systemic disease with clinical, patient reported and economic consequences. J Hepatol . 2016;65(1 Suppl):S109–S119. doi:10.1016/j.jhep.2016.07.005 27641981
   PubMed Web of Science ®Google Scholar
• Younossi ZM , Henry L , Po J , et al. Systematic review with meta-analysis: extrahepatic manifestations in chronic hepatitis C virus-infected patients in East Asia. Aliment Pharmacol Ther . 2019;49(6):644–653. doi:10.1111/apt.15131 30761562
   PubMed Web of Science ®Google Scholar
• Roth D , Bloom RD , Molnar MZ , et al. KDOQI US commentary on the 2018 KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C. Am J Kidney Dis . 2020;75(5):665–683. doi:10.1053/j.ajkd.2019.12.016 32279907
   PubMed Web of Science ®Google Scholar
• Garabed Eknoyan M , Norbert Lameire M , Co-Chairs FK , Kai-Uwe Eckardt M , Co-Chair IP . KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Guideline. Off J Int Soc Nephrol . 2013;3(1):1–150. doi:10.1038/kisup.2012.73
   Google Scholar
• Kim JK , Park JT , Oh HJ , et al. Estimating average glucose levels from glycated albumin in patients with end-stage renal disease. Yonsei Med J . 2012;53(3):578–586. doi:10.3349/ymj.2012.53.3.578 22477003
   PubMed Web of Science ®Google Scholar
• Nathan DM , Kuenen J , Borg R , et al. Translating the A1C assay into estimated average glucose values. Diabetes Care . 2008;31(8):1473–1478. doi:10.2337/dc08-0545 18540046
   PubMed Web of Science ®Google Scholar
• Rodriguez-Segade S , Rodriguez J , Paz JM , Camina F . Translating the A1C assay into estimated average glucose values: response to Nathan et al. Diabetes Care . 2009;32(1):e10; author reply e12. doi:10.2337/dc08-1214
   Google Scholar
• Stevens LA , Coresh J , Schmid CH , et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3418 individuals with CKD. Am J Kidney Dis . 2008;51(3):395–406. doi:10.1053/j.ajkd.2007.11.018 18295055
   PubMed Web of Science ®Google Scholar
• Avramovic G , Oprea C , Surey J , et al. HepCare Europe-A service innovation project. HepCheck: characteristics of the patient population with active infection as defined by HCV RNA. Int J Infect Dis . 2020;91:246–251. doi:10.1016/j.ijid.2019.11.027 31785401
   PubMed Web of Science ®Google Scholar
• Crews DC , Bello AK , Saadi G . 2019 World Kidney Day Editorial - burden, access, and disparities in kidney disease. J Bras Nefrol . 2019;41(1):1–9. doi:10.1590/2175-8239-JBN-2018-0224 31063178
   PubMedGoogle Scholar
• Ammirati AL . Chronic kidney disease. Rev Assoc Med Bras . 2020;66(Suppl 1):s03–s09. doi:10.1590/1806-9282.66.S1.3
   PubMed Web of Science ®Google Scholar
• Gundling F , Schumm-Draeger PM , Schepp W . Der hepatogene Diabetes - aktueller Stand der Diagnostik und Therapie [Hepatogenous diabetes - diagnostics and treatment]. Z Gastroenterol . 2009;47(5):436–445. doi:10.1055/s-0028-1109200 19418413
   PubMed Web of Science ®Google Scholar
• Iliescu L , Mercan-Stanciu A , Toma L , Ioanitescu ES , Severe A . Case of hyperglycemia in a kidney transplant recipient undergoing interferon-free therapy for chronic Hepatitis C. Acta Endocrinol (Buchar) . 2018;14(4):533–538. doi:10.4183/aeb.2018.533 31149309
   PubMed Web of Science ®Google Scholar
• Chlup R , Ehrmann J . Zvlastnosti diagnostiky a lecby diabetu u jaternich onemocneni. [Special aspects of diagnosis and therapy of diabetes in liver diseases]. Vnitr Lek . 2001;47(5):320–323.11395877
   PubMedGoogle Scholar
• Petrides AS . Der Hepatogene Diabetes: pathophysiologie, therapeutische Besonderheiten und Prognose [Hepatogenic diabetes: pathophysiology, therapeutic options and prognosis]. Z Gastroenterol . 1999;Suppl 1:15–21.
   Google Scholar
• Zhang X , Shen W , Shen DM . [A clinical analysis of liver disease patients with abnormal glucose metabolism]. Zhonghua Gan Zang Bing Za Zhi . 2006;14(4):289–292. (Chinese).16635301
   PubMedGoogle Scholar
• Mostafa A , Mohamed MK , Saeed M , et al. Hepatitis C infection and clearance: impact on atherosclerosis and cardiometabolic risk factors. Gut . 2010;59(8):1135–1140. doi:10.1136/gut.2009.202317 20584782
   PubMed Web of Science ®Google Scholar
• Du Y , Zhang S , Hu M , et al. Association between hepatitis B virus infection and chronic kidney disease: a cross-sectional study from 3 million population aged 20 to 49 years in rural China. Medicine . 2019;98(5):e14262. doi:10.1097/MD.0000000000014262 30702585
   PubMed Web of Science ®Google Scholar
• National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis . 2002;39(2 Suppl 1):S1–266.11904577
   PubMed Web of Science ®Google Scholar
• Endo M , Kumakura H , Kanai H , et al. Prevalence and risk factors for renal artery stenosis and chronic kidney disease in Japanese patients with peripheral arterial disease. Hypertensi Res . 2010;33(9):911–915. doi:10.1038/hr.2010.93
   Web of Science ®Google Scholar
• Hostetter TH , Olson JL , Rennke HG , Venkatachalam MA , Brenner BM . Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol . 1981;241(1):F85–93. doi:10.1152/ajprenal.1981.241.1.F85 7246778
   PubMed Web of Science ®Google Scholar
• Stevens LA , Coresh J , Greene T , Levey AS . Assessing kidney function–measured and estimated glomerular filtration rate. N Engl J Med . 2006;354(23):2473–2483. doi:10.1056/NEJMra054415 16760447
   PubMed Web of Science ®Google Scholar
• Stevens LA , Levey AS . Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol . 2009;20(11):2305–2313. doi:10.1681/ASN.2009020171 19833901
   PubMed Web of Science ®Google Scholar
• Murata K , Baumann NA , Saenger AK , Larson TS , Rule AD , Lieske JC . Relative performance of the MDRD and CKD-EPI equations for estimating glomerular filtration rate among patients with varied clinical presentations. Clin J Am Soc Nephrol . 2011;6(8):1963–1972. doi:10.2215/CJN.02300311 21737852
   PubMed Web of Science ®Google Scholar
• Shlipak MG , Matsushita K , Arnlov J , et al. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med . 2013;369(10):932–943. doi:10.1056/NEJMoa1214234 24004120
   PubMed Web of Science ®Google Scholar
• Stevens LA , Schmid CH , Greene T , et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int . 2009;75(6):652–660. doi:10.1038/ki.2008.638 19119287
   PubMed Web of Science ®Google Scholar
• American Diabetes A. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020. Diabetes Care . 2020;43(Suppl 1):S14–S31. doi:10.2337/dc20-S002 31862745
   PubMed Web of Science ®Google Scholar
• Drummond CA , Brewster PS , He W , et al. Cigarette smoking and cardio-renal events in patients with atherosclerotic renal artery stenosis. PLoS One . 2017;12(3):e0173562. doi:10.1371/journal.pone.0173562 28306749
   PubMed Web of Science ®Google Scholar
• Eloueyk AK , Alameddine RY , Osta BA , Awad DM . Correlations between serum inflammatory markers and comorbidities in patients with end-stage renal disease. J Taibah Univ Med Sci . 2019;14(6):547–552. doi:10.1016/j.jtumed.2019.10.003 31908643
   PubMed Web of Science ®Google Scholar
• Becares N , Harmala S , China L , et al. Immune regulatory mediators in plasma from patients with acute decompensation are associated with 3-month mortality. Clin Gastroenterol Hepatol . 2020;18(5):1207–1215 e6. doi:10.1016/j.cgh.2019.08.036 31446184
   PubMed Web of Science ®Google Scholar
• Fukuda K , Imai Y , Hiramatsu N , et al. Renal impairment during the treatment of telaprevir with peginterferon and ribavirin in patients with chronic hepatitis C. Hepatol Res . 2014;44(12):1165–1171. doi:10.1111/hepr.12229 24033816
   PubMed Web of Science ®Google Scholar
• Mauss S , Hueppe D , Alshuth U . Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir. Hepatology . 2014;59(1):46–48. doi:10.1002/hep.26602 23813604
   PubMed Web of Science ®Google Scholar